Program
Accelerating Pharma's New Era of Efficiency and Sustainability
A Virtual Symposium on Catalysis and Biocatalysis
At our exclusive two-day virtual symposium you can explore the latest developments in catalysis and biocatalysis. Check out the program below.
Please note: The mentioned timings are for Eastern Standard Time (EST) and Central European Time (CET). To convert the timings to your individual timezone please click here.
|
Day 1 | Tuesday, November 7 |
9:00 a.m. (EST) / 3:00 p.m. (CET)
Welcome & Introduction
Dr. Stefan Randl
Head of Drug Substance
Evonik
9:10 a.m. (EST) / 3:10 p.m. (CET)
Non-noble metal catalysis as a key tool for sustainable and practical synthesis of bioactive compounds
Prof. Dr. Matthias Beller
Scientific Director and Head of Applied Homogeneous Catalysis
Leibniz Institute for Catalysis
9:40 a.m. (EST) / 3:40 p.m. (CET)
High throughput screening (HTS) for catalyst selection
Dr. Konrad Moebus
Head of R&D and Applied Technology
Evonik
10:10 a.m. (EST) / 4:10 p.m. (CET)
Scale-up considerations for batch chemo-catalysis
Dr. James Bruno
Owner
Chemical & Pharmaceutical Solutions
10:40 a.m. (EST) / 4:40 p.m. (CET)
Coffee break
10:50 a.m. (EST) / 4:50 p.m. (CET)
Homogeneous Catalyst reclamation/refining
William White
Manager and Head of Projects, PR&D
Evonik
11:10 a.m. (EST) / 5:10 p.m. (CET)
Process Development and Scale-up of Continuous Hydrogenation from Lab Scale to Pilot Plant in a Trickle Bed Reactor
Dr. Onkar Manjrekar
Principal Research Scientist
AbbVie
11:40 a.m. (EST) / 5:40 p.m. (CET)
Fireside chat
Moderated roundtable discussion with our experts including audience Q&A.
Panelists:
- Dr. Onkar Manjrekar
Principal Research Scientist
AbbVie - Dr. Konrad Moebus
Head of R&D and Applied Technology
Evonik - William White
Manager and Head of Projects, PR&D
Evonik - Dr. James Bruno
Owner
Chemical & Pharmaceutical Solutions
Facilitator:
- Dr. Hans-Henning Wenk
Vice President R&D
Evonik
12:00 p.m. (EST) / 6:00 p.m. (CET)
Wrap up
Dr. Stefan Randl
Head of Drug Substance
Evonik
12:10 p.m. (EST) / 6:10 p.m. (CET)
End of day 1
|
Day 2 | Wednesday, November 8 |
9:00 a.m. (EST) / 3:00 p.m. (CET)
Introduction to day 2
Dr. Bettina Munsch
Head of Product Line Life Science & Performance Catalysts
Evonik
09:10 a.m. (EST) / 3:10 p.m. (CET)
Continuous Hydrogenation in Trickle Bed Reactors - An Emerging Technology in Pharma
10:00 a.m. (EST) / 4:00 p.m. (CET)
The call for Flow Chemistry
ShaRee Thomas
Head of PMC, AMC and OFC Tech Center
Evonik
10:20 a.m. (EST) / 4:20 p.m. (CET)
Coffee break
10:30 a.m. (EST) / 4:30 p.m. (CET)
Biocatalysis in Pharma-Synthesis: From the Design of Efficient Processes to Novel Retrosynthetic Pathways for Pharmaceuticals
Prof. Dr. Harald Gröger
Professor of Industrial Organic Chemistry and Biotechnology
University of Bielefeld
11:00 a.m. (EST) / 5:00 p.m. (CET)
Single & Cascading Whole Cell Biocatalytic Reactions
Dr. Steffen Osswald
Director Biotechnology; Process Design & DSP BiotechHub
Evonik
11:30 a.m. (EST) / 5:30 p.m. (CET)
Fireside chat
Moderated roundtable discussion with our experts including audience Q&A.
Panelists:
- Lee Edwards
Scientific Leader, GSK Fellow Primary Continuous Manufacturing
GSK - Prof. Dr. Harald Gröger
Professor of Industrial Organic Chemistry and Biotechnology
University of Bielefeld - Dr. Steffen Osswald
Director Biotechnology; Process Design & DSP BiotechHub
Evonik - ShaRee Thomas
Head of PMC, AMC and OFC Tech Center
Evonik
Facilitator:
- Dr. James Bruno
Owner
Chemical & Pharmaceutical Solutions
11:50 p.m. (EST) / 5:50 p.m. (CET)
Wrap up
Dr. Bettina Munsch
Head of Product Line Life Science & Performance Catalysts
Evonik
